Dexcom Inc. logo

Dexcom Inc. (DXCM)

Market Closed
6 Mar, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
68. 10
-2.59
-3.66%
$
28.43B Market Cap
134.71 P/E Ratio
- Div Yield
3,930,510 Volume
1.43 Eps
$ 70.69
Previous Close
Day Range
67.64 69.86
Year Range
54.11 89.98
Want to track DXCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DXCM earnings report is expected in 47 days (23 Apr 2026)
Class Action Announcement for DexCom, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against DexCom, Inc.

Class Action Announcement for DexCom, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against DexCom, Inc.

RADNOR, PA / ACCESSWIRE / August 29, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. ("DexCom") (NASDAQ:DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between January 8, 2024 to July 25, 2024, inclusive (the "Class Period") The lead plaintiff deadline is October 21, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered DexCom losses, you may CLICK HERE or go to: Click Here Please CLICK HERE to view our video or copy and paste this link into your browser: Click Here You can also contact attorney Jonathan Naji, Esq.

Accesswire | 1 year ago
A Lawsuit Has Been Filed For Possible Securities Fraud And DexCom Inc. Stakeholders Should Contact The Schall Law Firm

A Lawsuit Has Been Filed For Possible Securities Fraud And DexCom Inc. Stakeholders Should Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

NEW YORK, NY / ACCESSWIRE / August 29, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / August 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DexCom securities between January 8, 2024, and July 25, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - DXCM

NEW YORK, NY / ACCESSWIRE / August 29, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - DXCM

October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - DXCM

NEW YORK, NY / ACCESSWIRE / August 29, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM INVESTOR NOTICE: DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

DXCM INVESTOR NOTICE: DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, CA / ACCESSWIRE / August 28, 2024 / Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of DexCom, Inc. (NASDAQ:DXCM) securities between January 8, 2024 and July 25, 2024, both dates inclusive (the "Class Period"), have until October 21, 2024 to seek appointment as lead plaintiff of the DexCom class action lawsuit. Captioned Alonzo v.

Accesswire | 1 year ago
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM

DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – DXCM

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, PA / ACCESSWIRE / August 28, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. ("DexCom") (NASDAQ:DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between January 8, 2024 to July 25, 2024, inclusive (the "Class Period") The lead plaintiff deadline is October 21, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered DexCom losses, you may CLICK HERE or go to: Click Here Please CLICK HERE to view our video or copy and paste this link into your browser: Click Here You can also contact attorney Jonathan Naji, Esq.

Accesswire | 1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Accesswire | 1 year ago
Loading...
Load More